Health Care [ 11/12 ] | Biotechnology [ 53/76 ]
NASDAQ | Common Stock
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases.
The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease.
It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.
The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019.
Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 15, 24 | -0.21 Increased by +36.36% | -0.15 Decreased by -40.00% |
| May 16, 24 | -0.15 Increased by +67.39% | -0.20 Increased by +25.00% |
| Mar 19, 24 | -0.34 Increased by +42.37% | -0.42 Increased by +19.05% |
| Nov 14, 23 | -0.29 Increased by +41.06% | -0.38 Increased by +22.45% |
| Aug 15, 23 | -0.33 Increased by +19.51% | -0.44 Increased by +25.00% |
| May 15, 23 | -0.46 Decreased by -39.39% | -0.42 Decreased by -9.52% |
| Mar 17, 23 | -0.59 Decreased by -55.26% | -0.25 Decreased by -136.00% |
| Nov 11, 22 | -0.50 Increased by +16.67% | -0.53 Increased by +5.66% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 123.10 K Increased by +5.11% | -5.98 M Decreased by -29.00% | Decreased by -4.86 K% Decreased by -22.73% |
| Mar 31, 24 | 202.45 K Increased by +32.83% | -4.34 M Increased by +13.26% | Decreased by -2.15 K% Increased by +34.70% |
| Dec 31, 23 | 311.40 K Increased by +66.70% | -5.64 M Decreased by -17.28% | Decreased by -1.81 K% Increased by +29.65% |
| Sep 30, 23 | 495.48 K Increased by +9.58% | -4.77 M Decreased by -12.39% | Decreased by -962.98% Decreased by -2.57% |
| Jun 30, 23 | 117.12 K Decreased by -78.39% | -4.64 M Decreased by -34.47% | Decreased by -3.96 K% Decreased by -522.17% |
| Mar 31, 23 | 152.41 K Decreased by -21.80% | -5.01 M Decreased by -100.00% | Decreased by -3.29 K% Decreased by -100.00% |
| Dec 31, 22 | 186.80 K Decreased by -68.07% | -4.81 M Decreased by -72.29% | Decreased by -2.58 K% Decreased by -439.66% |
| Sep 30, 22 | 452.17 K Increased by +11.95% | -4.25 M Decreased by -9.97% | Decreased by -938.87% Increased by +1.76% |